Bruno BJ, Weavil JC, Ogle J, Chidambaram N, et al. Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial. Hepatology 2024 Nov 8. doi: 10.1097/HEP.0000000000001146.
PMID: 39513970